Measurable Residual Disease Guided Therapy in Intermediate-Risk AML Patients Compared to an Unguided Cohort Using Propensity Score Matching
Jesse M. Tettero,Lok Lam Ngai,Costa Bachas,Dimitri A. Breems,Thomas Fischer,Bjørn Tore Gjertsen,Patrycja Gradowska,Laimonas Griskevicius,Jeroen J.W.M. Janssen,Gunnar Juliusson,Johan A. Maertens,Markus G Manz,Thomas Pabst,Jakob Passweg,Kimmo Porkka,Peter JM Valk,Bob Lowenberg,Gert J. Ossenkoppele,Jacqueline Cloos Blood（2022）
关键词
measurable residual disease,unguided cohort,intermediate-risk
AI 理解论文
溯源树
样例
